Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ on May 20, 2024 at 11:30 a.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About OptinoseOptinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.

Optinose Investor ContactJonathan Neelyjonathan.neely@optinose.com267.521.0531

OptiNose (NASDAQ:OPTN)
過去 株価チャート
から 5 2024 まで 6 2024 OptiNoseのチャートをもっと見るにはこちらをクリック
OptiNose (NASDAQ:OPTN)
過去 株価チャート
から 6 2023 まで 6 2024 OptiNoseのチャートをもっと見るにはこちらをクリック